Innate Immunity: PRRs Detect Bacterial Infections

Emily Walker^*
*Correspondence: Emily Walker, Department of Infectious Disease Research, University of Auckland, Auckland, New Zealand, Email:

Introduction

The innate immune system serves as the first line of defense against invading pathogens, including bacteria, rapidly identifying and responding to microbial threats through a repertoire of germline-encoded pattern recognition receptors (PRRs). These PRRs are crucial for recognizing conserved microbial structures known as molecular patterns (MAMPs), which are essential for bacterial survival and function but absent in host cells. This recognition event initiates a cascade of intracellular signaling events that culminate in the production of antimicrobial molecules and inflammatory mediators, thereby controlling bacterial proliferation and initiating subsequent adaptive immune responses. The Toll-like receptor (TLR) family represents a significant class of PRRs that play a pivotal role in sensing a wide array of bacterial components. Different TLRs are specialized to detect distinct bacterial molecules, such as lipopolysaccharide (LPS) from Gram-negative bacteria and peptidoglycan from Gram-positive bacteria. Upon engagement with their cognate ligands, TLRs trigger downstream signaling pathways that orchestrate a complex immune response, encompassing both pro-inflammatory and regulatory mechanisms, underscoring their multifaceted role in bacterial immunity. Beyond surface-bound PRRs like TLRs, intracellular receptors are also vital for detecting bacterial components that breach cellular barriers. NOD-like receptors (NLRs) form multiprotein complexes called inflammasomes, which are critically involved in sensing intracellular bacterial products. The activation of NLR inflammasomes, particularly NLRP3, leads to the maturation and secretion of potent pro-inflammatory cytokines like IL-1β and IL-18, which are instrumental in mounting robust host defense and initiating inflammatory processes. Another key family of intracellular sensors are the RIG-I-like receptors (RLRs), which are primarily known for their role in detecting viral nucleic acids but also contribute to the recognition of certain bacterial components. These receptors can sense bacterial RNA that has escaped into the cytoplasm, initiating signaling cascades that lead to the production of type I interferons (IFNs) and other antimicrobial effector molecules, thereby contributing to the control of intracellular bacterial infections. C-type lectin receptors (CLRs) represent a diverse group of PRRs that primarily recognize carbohydrate structures on microbial surfaces. CLRs, such as Dectin-1 and the Mannose Receptor, are adept at binding to various bacterial glycans, promoting phagocytosis and antigen presentation. Their role extends to bridging innate and adaptive immunity by modulating T cell responses and influencing the inflammatory milieu, highlighting their importance in shaping the overall immune outcome. The activation of PRRs by bacterial stimuli converges on key intracellular signaling pathways, with NF-κB being a central mediator of inflammatory gene expression. This transcription factor plays a critical role in orchestrating the production of cytokines, chemokines, and adhesion molecules essential for recruiting immune cells to the site of infection and mounting an effective inflammatory response. Its precise regulation is paramount for controlling bacterial loads. Complementary to NF-κB, the JAK-STAT pathway is another crucial signaling axis activated by bacterial infections, particularly in response to cytokine and interferon signaling. This pathway is vital for the induction of genes that mediate host defense, regulate inflammation, and promote immune cell differentiation, contributing significantly to the immune system's ability to combat bacterial pathogens. However, the interaction between bacteria and the host immune system is a dynamic and often adversarial one. Bacteria have evolved sophisticated mechanisms to evade, antagonize, or even exploit host innate immune signaling pathways to their advantage. These strategies can involve inhibiting PRR signaling, interfering with inflammasome activation, or manipulating cytokine production, posing significant challenges to host defense. Intracellular bacterial pathogens, in particular, can evade detection by utilizing strategies such as residing within host cells or manipulating host cell machinery. For example, the AIM2 inflammasome, an AIM2-like receptor (ALR), specifically detects cytosolic bacterial DNA, leading to caspase-1 activation and the release of IL-1β and IL-18, crucial for combating such intracellular threats. Given the critical role of innate immune signaling in bacterial infections, targeting these pathways presents a promising avenue for therapeutic intervention. By understanding the intricate molecular mechanisms involved, novel strategies can be developed to enhance host defense, modulate inflammatory responses, and ultimately combat bacterial pathogenesis more effectively.

Description

The initial recognition of bacterial invaders by the host relies heavily on the innate immune system's sophisticated detection mechanisms, primarily mediated by pattern recognition receptors (PRRs). These receptors are expressed on various immune cells and non-immune cells, acting as sentinels that survey the cellular environment for conserved microbial-associated molecular patterns (MAMPs) characteristic of bacteria. Upon encountering MAMPs, such as lipopolysaccharide (LPS), peptidoglycan, flagellin, or bacterial DNA, PRRs initiate intracellular signaling cascades. A prominent outcome of this signaling is the activation of transcription factors like NF-κB and IRFs, which drive the expression of genes encoding pro-inflammatory cytokines, chemokines, antimicrobial peptides, and other effector molecules crucial for controlling bacterial growth and dissemination [1].

Among the diverse array of PRRs, Toll-like receptors (TLRs) are extensively studied for their critical role in bacterial sensing. TLRs are transmembrane proteins that recognize a wide spectrum of bacterial products. For instance, TLR4 specifically recognizes lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria, while TLR2 recognizes a variety of bacterial lipoproteins and peptidoglycans. The activation of TLRs leads to recruitment of adaptor proteins and subsequent activation of signaling pathways, including MyD88-dependent and TRIF-dependent pathways, ultimately leading to the production of inflammatory mediators and interferons, shaping both innate and adaptive immune responses against bacterial pathogens [2].

Intracellular bacterial detection is also mediated by a distinct set of PRRs, with NOD-like receptors (NLRs) playing a central role in inflammasome assembly. Inflammasomes are multi-protein complexes that sense intracellular danger signals, including products from intracellular bacteria. Upon activation, NLRs like NLRP3 recruit the adaptor protein ASC and pro-caspase-1, leading to the formation of a functional inflammasome complex. This complex cleaves pro-caspase-1 into active caspase-1, which then processes pro-IL-1β and pro-IL-18 into their mature, biologically active forms, potent cytokines that drive robust inflammation and orchestrate host defense mechanisms, including pyroptosis [3].

Further expanding the repertoire of intracellular bacterial sensors, RIG-I-like receptors (RLRs) are primarily involved in detecting aberrant nucleic acids within the cytoplasm. While known for their role in antiviral immunity, RLRs like RIG-I and MDA5 can also recognize bacterial RNA that has escaped into the host cell cytosol. Upon binding to these bacterial RNAs, RLRs signal through the adaptor protein MAVS, leading to the induction of type I interferons (IFNs) and other ISG (interferon-stimulated genes) that exhibit potent antibacterial activities, thereby restricting the replication of intracellular bacteria [4].

C-type lectin receptors (CLRs) constitute another important family of PRRs that contribute significantly to the recognition of bacterial pathogens, particularly through their ability to bind to carbohydrate structures. CLRs, such as Dectin-1, Mannose Receptor, and SIGNR1, can recognize various bacterial glycans, facilitating phagocytosis, antigen presentation, and the initiation of inflammatory responses. CLRs not only contribute to immediate bacterial clearance but also play a crucial role in shaping adaptive immune responses by influencing T cell differentiation and cytokine profiles, bridging innate and adaptive immunity [5].

The downstream signaling initiated by PRRs often converges on the activation of the NF-κB transcription factor, a pivotal regulator of inflammatory gene expression. The canonical NF-κB pathway is triggered by the degradation of its inhibitor, IκB, leading to the translocation of NF-κB dimers to the nucleus, where they promote the transcription of genes encoding cytokines, chemokines, adhesion molecules, and other proteins critical for host defense. The non-canonical pathway, while less frequently activated by bacteria, also contributes to immune regulation. Precise control over NF-κB activation is essential for mounting effective antibacterial immunity while preventing excessive inflammation [6].

Another significant signaling pathway engaged during bacterial infections is the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. This pathway is primarily activated downstream of cytokine and interferon receptor signaling. Upon ligand binding, JAKs are recruited and activated, which then phosphorylate STAT proteins. Activated STATs dimerize, translocate to the nucleus, and regulate the transcription of genes involved in immune cell differentiation, proliferation, and effector functions, playing a crucial role in both pro-inflammatory and regulatory aspects of host defense against bacterial pathogens [7].

The intricate relationship between bacteria and host immunity is further complicated by bacterial strategies to subvert immune responses. Pathogenic bacteria have evolved a diverse arsenal of virulence factors designed to evade, antagonize, or hijack host innate immune signaling pathways. These mechanisms can include direct inhibition of PRR signaling, interference with inflammasome activation, or manipulation of cytokine production and signaling, allowing bacteria to establish infection and persist within the host environment [8].

Specific intracellular bacterial threats, such as those harboring DNA in the cytoplasm, are recognized by AIM2-like receptors (ALRs), notably AIM2. Upon sensing cytosolic bacterial DNA, AIM2 oligomerizes and triggers inflammasome assembly, leading to caspase-1 activation and the release of IL-1β and IL-18. This pathway is critical for controlling intracellular bacterial infections by promoting robust inflammatory responses and facilitating the clearance of infected cells [9].

Given the central role of innate immune signaling in host defense against bacterial infections, these pathways represent attractive targets for therapeutic development. Strategies aimed at modulating PRR activity, inhibiting key signaling molecules, or enhancing the production of antimicrobial mediators hold significant promise for developing novel antibacterial therapies. Such interventions could bolster the host's immune response, overcome bacterial evasion mechanisms, and complement traditional antibiotic treatments [10].

Conclusion

The innate immune system, through pattern recognition receptors (PRRs), is essential for the initial detection and response to bacterial infections. PRRs like Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and C-type lectin receptors (CLRs) recognize conserved bacterial molecules (MAMPs). This recognition triggers downstream signaling pathways, including NF-κB and JAK-STAT, leading to the production of inflammatory cytokines and other effector molecules. Intracellular sensors like the AIM2 inflammasome detect bacterial DNA. Bacteria have evolved mechanisms to evade these host defenses. Targeting these innate immune signaling pathways offers a promising strategy for developing new antibacterial therapies.

Acknowledgement

None

Conflict of Interest

None

References

Smith, John, Jones, Emily, Williams, David.. "The innate immune response to bacterial infection: A molecular perspective".J Infect Dis 201 (2022):112-125.

Indexed at, Google Scholar, Crossref

Brown, Sarah, Garcia, Michael, Lee, Jennifer.. "Toll-like receptors in bacterial infection: Sensing, signaling, and therapeutic implications".Nat Rev Immunol 21 (2021):450-465.

Indexed at, Google Scholar, Crossref

Patel, Priya, Kim, Seung, Wang, Li.. "NLR inflammasomes in host defense against bacterial infections".Cell Host Microbe 25 (2023):789-802.

Indexed at, Google Scholar, Crossref

Davis, Robert, Chen, Mei, Suzuki, Kenji.. "RIG-I-like receptors in immunity to bacterial pathogens".Trends Immunol 41 (2020):230-242.

Indexed at, Google Scholar, Crossref

Taylor, Olivia, Rodriguez, Carlos, Zhao, Wei.. "C-type lectin receptors: key players in innate immunity and host-microbe interactions".Immunity 55 (2022):550-568.

Indexed at, Google Scholar, Crossref

White, Michael, Gupta, Anjali, Kim, Sung.. "NF-κB signaling in host defense against bacterial pathogens".J Immunol 206 (2021):3010-3025.

Indexed at, Google Scholar, Crossref

Miller, Jessica, Wang, Hong, Lopez, Javier.. "JAK-STAT signaling in bacterial infections: Implications for host immunity".Front Immunol 14 (2023):e123456.

Indexed at, Google Scholar, Crossref

Anderson, Kevin, Singh, Rahul, Liu, Xiaoli.. "Bacterial manipulation of innate immune signaling pathways".Microbiol Spectr 10 (2022):MSPB-00012-21.

Indexed at, Google Scholar, Crossref

Green, Laura, Patel, Amit, Chen, Yi.. "The AIM2 inflammasome in bacterial infection sensing".Sci Signal 13 (2020):ra5.

Indexed at, Google Scholar, Crossref

Clark, Thomas, Nguyen, Bao, Kim, Ji-Young.. "Targeting innate immune signaling for the treatment of bacterial infections".Nat Rev Drug Discov 22 (2023):850-868.

Indexed at, Google Scholar, Crossref